Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/086900 stock hub

KOSDAQ/086900 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/086900is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
678.5B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/086900
In the news

Latest news · KOSDAQ/086900

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27
P25 9.8P50 17.1P75 31.9
Trailing P/E43.7
P25 12P50 23.1P75 39.5
ROE3.4
P25 -17.1P50 0.7P75 8.5
ROIC3.5
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/086900 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
233
Groups with data
11
Currency
KRW
Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
718
Enterprise value
KRW 708.8B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biotechnology
Isin
KR7086900008
Last refreshed
2026-05-10
Market cap
KRW 678.5B
Price
KRW 103,500
Price currency
KRW
Rev Per Employee
344,415,444.79x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/086900
Website
https://www.medytox.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
2.3%
EV Earnings
45.38x
EV/EBIT
75.69x
EV/EBITDA
24.08x
EV/FCF
15.49x
EV/Sales
2.87x
FCF yield
6.74%
Forward P/E
26.95x
P/B ratio
1.49x
P/E ratio
43.65x
P/S ratio
2.74x
PE Ratio10 Y
72.03x
PE Ratio3 Y
133.73x
PE Ratio5 Y
88.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
6.74%
EBITDA Margin
14.86%
FCF margin
18.5%
Gross margin
57.76%
Gross Profit
KRW 142.8B
Gross Profit Growth
3.07%
Gross Profit Growth Q
9.26%
Gross Profit Growth3 Y
4.26%
Gross Profit Growth5 Y
14.09%
Net Income
KRW 15.6B
Net Income Growth
-2.13%
Net Income Growth Years
0%
Net Income Growth3 Y
-24.32%
Pretax Margin
2.66%
Profit Margin
6.71%
Profit Per Employee
KRW 21.8M
Profitable Years
5
ROA
1.74
Roa5y
2.91
ROCE
3.5
ROE
3.36
Roe5y
9.28
ROIC
3.45
Roic5y
4.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
-11.7%
Cagr15y
12.74%
Cagr1y
-39.84%
Cagr3y
-24.77%
Cagr5y
-7.7%
Div CAGR10
7.73%
Div CAGR3
2.94%
Div CAGR5
5.76%
EPS Growth
-0.23
EPS Growth Years
0
EPS Growth3 Y
-24.41
FCF Growth
64.39%
FCF Growth Q
-53.81%
FCF Growth3 Y
41.05%
OCF Growth
67.99%
OCF Growth Q
0.73%
OCF Growth10 Y
10.63%
OCF Growth3 Y
32.84%
OCF Growth5 Y
17.07%
Revenue Growth
8.17x
Revenue Growth Q
9.96x
Revenue Growth Quarters
2x
Revenue Growth Years
5x
Revenue Growth3 Y
8.22x
Revenue Growth5 Y
11.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
KRW 0.41
Assets
KRW 581.8B
Cash
KRW 48.9B
Current Assets
KRW 155.3B
Current Liabilities
KRW 104.8B
Debt
KRW 76.6B
Debt EBITDA
KRW 2.09
Debt Equity
KRW 0.17
Debt FCF
KRW 1.67
Equity
KRW 454.3B
Interest Coverage
25.68
Liabilities
KRW 127.5B
Long Term Assets
KRW 426.4B
Long Term Liabilities
KRW 22.7B
Net Cash
KRW -27.7B
Net Cash By Market Cap
KRW -4.08
Net Debt EBITDA
KRW 0.75
Net Debt Equity
KRW 0.06
Net Debt FCF
KRW 0.61
Tangible Book Value
KRW 446.8B
Tangible Book Value Per Share
KRW 68,153
WACC
6.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.48
Inventory Turnover
1.95
Net Working Capital
KRW 58.7B
Quick ratio
1.02
Working Capital
KRW 50.5B
Working Capital Turnover
KRW 3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.03%
Dividend Growth
9.09%
Dividend Growth Years
1%
Dividend per share
KRW 1,200
Dividend Years
16
Dividend Yield
1.16%
Ex Div Date
2025-09-29
Last Dividend
KRW 1,200
Payout Frequency
Annual
Payout Ratio
53.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-71.17%
1Y total return
-39.82%
200-day SMA
122,428.5
3Y total return
-57.42%
50-day SMA
109,022
50-day SMA vs 200-day SMA
50under200
5Y total return
-33%
All Time High
700,092
All Time High Change
-85.22%
All Time High Date
2018-07-10
All Time Low
10,316.5
All Time Low Change
903.25%
All Time Low Date
2009-01-16
ATR
3,506.9
Beta
0.47
Beta1y
0.65
Beta2y
0.5
Ch YTD
-14.32
High
104,800
High52
182,700
High52 Date
2025-05-09
High52ch
-43.35%
Low
102,400
Low52
96,400
Low52 Date
2026-04-06
Low52ch
7.37%
Ma50ch
-5.07%
Price vs 200-day SMA
-15.46%
RSI
44.12
RSI Monthly
39.74
RSI Weekly
37.27
Sharpe ratio
-1.04x
Sortino ratio
-1.22
Total Return
3.19%
Tr YTD
-14.32
Tr15y
504.21%
Tr1m
6.05%
Tr1w
-1.9%
Tr3m
-18.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
KRW 16.7B
Operating Income Growth
-18.04
Operating Income Growth3 Y
-29.03
Operating margin
6.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
5,122,910%
Net Borrowing
-5,583,652,470
Shares Insiders
20.79%
Shares Institutions
11.29%
Shares Out
6,555,181
Shares Qo Q
-14.63%
Shares Yo Y
-2.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
KRW 45.8B
Average Volume
35,216.85x
Bv Per Share
68,895.4
CAPEX
KRW -15.7B
Ch10y
-72.67
Ch15y
453.9
Ch1m
6.05
Ch1w
-1.9
Ch1y
-40.41
Ch3m
-18.12
Ch3y
-58.27
Ch5y
-35.31
Ch6m
-11.16
Change
0.39%
Change From Open
0.19
Close
103,100
Days Gap
0.19
Depreciation Amortization
20,066,601,000
Dollar Volume
3,037,518,000
Earnings Date
2026-05-15
EBIT
KRW 16.7B
EBITDA
KRW 36.7B
EPS
KRW 2,371
F Score
6
FCF
KRW 45.7B
FCF EV Yield
6.45x
FCF Per Share
KRW 6,979
Financing CF
-37,633,595,560
Fiscal Year End
December
Founded
2,000
Graham Number
60625.16056
Graham Upside
-41.42
Income Tax
KRW -9.1B
Investing CF
-20,628,001,870
Is Primary Listing
1
Last Earnings Date
2025-11-13
Last Report Date
2025-12-31
Last Split Date
2022-12-28
Last Split Type
Forward
Lynch Fair Value
KRW 11,855
Lynch Upside
-88.55
Ma150
118,692.7
Ma150ch
-12.8%
Ma20
105,140
Ma20ch
-1.56%
Net CF
2,726,472,040
Next Earnings Date
2026-05-15
Open
103,300
P FCF Ratio
14.83
P OCF Ratio
11.05
Payment Date
2025-10-30
Position In Range
45.83
Ppne
199,540,507,320
Price Date
2026-05-08
Price EBITDA
KRW 18.46
Ptbv Ratio
1.52
Relative Volume
0.86x
Revenue
247,290,289,360x
SBC By Revenue
-0.04x
Share Based Comp
-97,169,000
Tax By Revenue
-3.67x
Tr6m
-11.16%
Volume
29,348
Z Score
6.12
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/086900 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.2%
$1200 annual per share
Payout ratio
+53.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.8%
1 consecutive years of growth
Total shareholder yield
+3.2%
Next ex-dividend date: 2025-09-29
Performance

KOSDAQ/086900 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-39.8%
S&P 500 1Y: n/a
3Y total return
-57.4%
S&P 500 3Y: n/a
5Y total return
-33.0%
S&P 500 5Y: n/a
10Y total return
-71.2%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/086900?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.3%
Share of float held by funds and institutions
Insider ownership
+20.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.0%
Negative means the company is buying back shares.
Technical

KOSDAQ/086900 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.1
Neutral momentum band
Price vs 200-day MA
-15.5%
50/200-day relationship not available
Beta (5Y)
0.47
Less volatile than the market
Sharpe ratio
-1.04
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/086900

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/086900 stock rating?

kosdaq/086900 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/086900 analysis?

The full report lives at /stocks/kosdaq/086900/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/086900?

The latest report frames kosdaq/086900 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/086900 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.